Istanbul Hosts Key Medical Milestones: The Global ACLF Consensus and New Research on Candida Species
Istanbul recently served as the convening location for significant medical research and consensus building. During the APASL 2026 conference, a day-long meeting resulted in 'The Istanbul Document,' which outlines the Global Consensus on the real-world applicability of Type-A and Type-B Acute-on-Chronic Liver Failure (ACLF) across different continents. In a separate scientific development, researchers from the Department of Medical Microbiology at Istanbul University-Cerrahpasa published a detailed study on the etiological agents and antifungal susceptibility of rare Candida species responsible for causing candidemia.
Sources: https://link.springer.com/article/10.1007/s12072-026-global-aclf-consensus-istanbul-document https://www.nature.com/articles/etiological-agents-antifungal-susceptibility-rare-candida-species/